Results 271 to 280 of about 110,409 (295)

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2021
Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto   +2 more
exaly  

Intrathoracic Mesothelioma

Radiology, 1963
W B, HUTCHINSON, M J, FRIEDENBERG
openaire   +2 more sources

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nature Medicine, 2021
Patrick Forde, Valsamo Anagnostou, Suzanne E Dahlberg   +2 more
exaly  

Pleural mesotheliomas

The American Journal of Surgery, 1959
K, STEPHANOPOULOS, H C, CATSARAS
openaire   +2 more sources

Pericardial Mesothelioma

The Annals of Thoracic Surgery, 1967
J M, Van de Water, W H, Allen
openaire   +2 more sources

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Nature Genetics, 2023
Lise Mangiante, Nicolas Alcala, Abel Gonzalez-Perez   +2 more
exaly  

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Ca-A Cancer Journal for Clinicians, 2019
Michele Carbone, Prasad S Adusumilli, Paul Baas   +2 more
exaly  

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

Ca-A Cancer Journal for Clinicians, 2018
David A Mahvi, Rong Liu, Yolonda L Colson   +2 more
exaly  

Novel insights into mesothelioma biology and implications for therapy

Nature Reviews Cancer, 2017
Sanjay Popat, Dean A Fennell
exaly  

Deep learning-based classification of mesothelioma improves prediction of patient outcome

Nature Medicine, 2019
Mikhail Zaslavskiy, Nolwenn Le Stang
exaly